Launching a new website.
Gabather is launching a new website. It will be available through the old URL, www.gabather.com. A new function on the site is enabling users to view the events Gabather will be attending.
Gabather will be attending the following upcoming events:
- French Swedish Life Science Day, 20th of October, Paris.
- Shareholder meeting at Erik Penser Bank, 27th of October, Stockholm.
- BIO-Europe, 7-9th of November, Cologne.
- Nordic-American Life Science Conference, 1st of December, New York.
- JP Morgan Healthcare conference, 8-11th of January 2017, San Francisco.
More information about these events are available on our website.
Gabather AB
Bert Junno, CEO
E-mail: [email protected]
Gabather AB
Gabather was founded in 2014 as a result of more than ten years of collaborative research between Lund University (Sweden) and the Research Institute of Biological Chemistry in Roskilde (Denmark). The aim of the company is to develop novel small molecule drugs to treat diseases with an origin in the central nervous system. Gabather founders are the Forskarpatent fund together with scientists Olov Sterner and Mogens Nielsen.
Om Gabather
Gabathers affärsidé är att utveckla nya läkemedel för att behandla sjukdomar inom det centrala nervsystemet med nya verkansvägar, större träffsäkerhet och mindre biverkningar.
